Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen‐inducible DNA recombinase variant CreERT2
Abstract
Inducible gene modification using the Cre/loxP system provides a valuable tool for the analysis of gene function in the active animal. GFAP‐Cre transgenic mice have been developed to achieve gene recombination in astrocytes, the most abundant cells of the central nervous system, with pivotal roles during brain function and pathology. Unfortunately, these mice displayed neuronal recombination as well, since the GFAP promoter is also active in embryonic radial glia, which possess a substantial neurogenic potential. To enable the temporal control of gene deletions in astrocytes only, we generated a transgenic mouse with expression of CreERT2, a fusion protein of the DNA recombinase Cre and a mutated ligand‐binding domain of the estrogen receptor, under the control of the human GFAP promoter. In offspring originating from crossbreedings of GFAP‐CreERT2‐transgenic mice with various Cre‐sensitive reporter mice, consecutive intraperitoneal injections of tamoxifen induced genomic recombination selectively in astrocytes of almost all brain regions. In Bergmann glia, which represent the main astroglial cell population of the cerebellum, virtually all cells showed successful gene recombination. When adult mice received cortical stab wound lesions, simultaneously given tamoxifen induced substantial recombination in reactive glia adjacent to the site of injury. These transgenic GFAP‐CreERT2 mice will allow the functional analysis of loxP‐modified genes in astroglia of the postnatal and adult brain.Keywords
This publication has 59 references indexed in Scilit:
- Functional Fluorescent Ca2+ Indicator Proteins in Transgenic Mice under TET ControlPLOS Biology, 2004
- Diversity of Functional Astroglial Properties in the Respiratory NetworkJournal of Neuroscience, 2004
- Visualization of S100B‐positive neurons and glia in the central nervous system of EGFP transgenic miceJournal of Comparative Neurology, 2003
- ER‐based double icre fusion protein allows partial recombination in forebrainGenesis, 2002
- GFAP promoter-controlled EGFP-expressing transgenic mice: A tool to visualize astrocytes and astrogliosis in living brain tissueGlia, 2000
- Inducible site-specific recombination in the brain 1 1Edited by M. YanivJournal of Molecular Biology, 1999
- Regulation of Cre Recombinase Activity by Mutated Estrogen Receptor Ligand-Binding DomainsBiochemical and Biophysical Research Communications, 1997
- Control of Memory Formation Through Regulated Expression of a CaMKII TransgeneScience, 1996
- Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Conditional gene targeting.Journal of Clinical Investigation, 1996